Response, “second look” status and survival in stage III–IV epithelial ovarian cancer treated with cis-dichlorodiammine platinum II (cis-platinum), adriamycin (ADR), and cytoxan (CTX)

Publisher Website
Google Scholar
Abstract
No abstract available